This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital.
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
PEA, Federico;BARALDO, Massimo
2016-01-01
Abstract
This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Br J Clin Pharmacol 812 341 348.pdf
non disponibili
Descrizione: ARTICOLO PRINCIPALE
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non pubblico
Dimensione
949.41 kB
Formato
Adobe PDF
|
949.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
